Sami-Sabinsa Group Limited (formerly Sami Labs Ltd), a pioneer and global leader in health science, is a leading producer of nutraceuticals, cosmeceuticals, standardized herbal extracts, fine chemicals, specialty chemicals, probiotics and enzymes.
Founded in 1988 by Dr. Muhammed Majeed, an internationally acclaimed scientist turned entrepreneur in the field of Evidence Based Medicine, the Group has independent research divisions including Natural Drugs, Phytochemistry, Synthetic Chemistry, Tissue Culture, Biotechnology, Analytical R&D, Biological Research, Microbiology, and Formulations R&D all of which coordinate in a synergistic work model to create products meeting international standards. A team of over 120 research scientists work tirelessly to discover and develop standardized natural extracts that render alternative therapy to emerging nutritional and health requirements across the globe.
Demonstrating its commitment to sustainable development, Sami-Sabinsa Group, under the visionary leadership of Dr. Majeed, pioneered the contract farming model deploying close to 40,000 acres of land in India. The Group has a sizeable patent portfolio comprising over 317 granted patents and 300 pending patent applications worldwide. Sami-Sabinsa Group manufactures its products as per global standards at its seven state-of-the-art manufacturing facilities located in Bengaluru, Hyderabad and Utah (USA). Our Bengaluru and Hyderabad facilities are FSSC 22000, FSSAI and USP GMP certified and our US facility is NSF GMP certified. Sami-Sabinsa is a global organization with presence in the USA (New Jersey & Utah), Australia, Canada, China, Germany, India, Indonesia, Japan, Malaysia, Philippines, Poland, South Africa, South Korea, Thailand, the United Arab Emirates (UAE) and Vietnam.